GB9721432D0 - Improved production of antibodies through the use of antigen antibody complexes - Google Patents
Improved production of antibodies through the use of antigen antibody complexesInfo
- Publication number
- GB9721432D0 GB9721432D0 GBGB9721432.4A GB9721432A GB9721432D0 GB 9721432 D0 GB9721432 D0 GB 9721432D0 GB 9721432 A GB9721432 A GB 9721432A GB 9721432 D0 GB9721432 D0 GB 9721432D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- antibodies
- improved production
- antibody complexes
- antigen antibody
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9606425.8A GB9606425D0 (en) | 1996-03-27 | 1996-03-27 | Improvements in and relating to the production of antibodies and test kits incorporating antibodies |
PCT/GB1997/000855 WO1997035884A1 (en) | 1996-03-27 | 1997-03-26 | Improved production of antibodies through the use of combinations of antigen and antibody, test kits incorporating said antibodies, and medical uses of said antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
GB9721432D0 true GB9721432D0 (en) | 1997-12-10 |
GB2314334A GB2314334A (en) | 1997-12-24 |
Family
ID=10791102
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9606425.8A Pending GB9606425D0 (en) | 1996-03-27 | 1996-03-27 | Improvements in and relating to the production of antibodies and test kits incorporating antibodies |
GB9721432A Withdrawn GB2314334A (en) | 1996-03-27 | 1997-03-26 | Improved production of antibodies through the use of antigen antibody complexes |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9606425.8A Pending GB9606425D0 (en) | 1996-03-27 | 1996-03-27 | Improvements in and relating to the production of antibodies and test kits incorporating antibodies |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU2169797A (en) |
DE (1) | DE19780326T1 (en) |
GB (2) | GB9606425D0 (en) |
WO (1) | WO1997035884A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001510827A (en) * | 1997-07-25 | 2001-08-07 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | Substituted 6-phenylphenanthridine |
US20070202117A1 (en) | 2005-12-22 | 2007-08-30 | Herman Groen | Compositions and Methods Of Modulating the Immune Response |
WO2008142483A2 (en) * | 2006-12-14 | 2008-11-27 | Plant Research International B.V. | Vaccine compositions and methods of use thereof |
SG10202009182RA (en) * | 2016-03-21 | 2020-11-27 | David Weiner | Dna antibody constructs and method of using same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0153871A3 (en) * | 1984-03-01 | 1987-07-01 | Centocor, Inc. | Antibody enhancement of immunogenicity of antigen |
US4879225A (en) * | 1986-06-20 | 1989-11-07 | Neorx Corporation | Enhanced production of antibodies utilizing insolubilized immune complexes |
US5332665A (en) * | 1991-12-18 | 1994-07-26 | The General Hospital Corporation | Species specific, high affinity monoclonal antibodies |
-
1996
- 1996-03-27 GB GBGB9606425.8A patent/GB9606425D0/en active Pending
-
1997
- 1997-03-26 DE DE19780326T patent/DE19780326T1/en not_active Withdrawn
- 1997-03-26 WO PCT/GB1997/000855 patent/WO1997035884A1/en active Application Filing
- 1997-03-26 AU AU21697/97A patent/AU2169797A/en not_active Abandoned
- 1997-03-26 GB GB9721432A patent/GB2314334A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO1997035884A1 (en) | 1997-10-02 |
WO1997035884A8 (en) | 2001-04-26 |
GB9606425D0 (en) | 1996-06-05 |
AU2169797A (en) | 1997-10-17 |
DE19780326T1 (en) | 1998-04-23 |
GB2314334A (en) | 1997-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL311926A1 (en) | Anti-alphav-integrinic monoclonal antibodies | |
IL128406A0 (en) | Monoclonal antibodies | |
EP0842948A4 (en) | ANTIFas LIGAND ANTIBODIES AND ASSAY METHOD BY USING THE SAME | |
IL147517A0 (en) | Monoclonal antibodies and immunoassay utilizing the same | |
EP0741144A4 (en) | Antiannexin-v monoclonal antibody, process for producing the same, and use therof | |
AU7072998A (en) | Immunoassays using anti-allotypic monoclonal antibodies | |
EP0977590A4 (en) | Human monoclonal antibodies | |
AU3923293A (en) | Human monoclonal antibodies and methods for human monoclonal antibody production | |
GB9721432D0 (en) | Improved production of antibodies through the use of antigen antibody complexes | |
EP0363712A3 (en) | Hybrid monoclonal antibodies, their production and use | |
ZA941645B (en) | Antibodies specifically reactive against human prostate specific antigen. | |
ZA951113B (en) | Tumor assosiated monoclonal antibody 123av16 | |
EP0889734A4 (en) | Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof | |
GB9718911D0 (en) | Monoclonal antibodies | |
ZA912695B (en) | Monoclonal anti-igm antibodies,their production and use,and hybridomas for producing the same | |
EP0446763A3 (en) | Antigen for producing anti-idiotype antibody, anti-idiotype antibody and method for producing the anti-idiotype antibody | |
AU4775899A (en) | Human monoclonal antibodies against the tumor antigen uk114 and lymphocyte cellsand hybridomas for their production | |
GB9515850D0 (en) | Broad specificity antibodies | |
IL94304A0 (en) | Novel tumor-associated antigen,antibodies,compositions and uses therefor | |
ZA912136B (en) | Anti-oncostatin m monoclonal antibodies | |
IL127249A0 (en) | Human monoclonal antibodies to the hepatitis b surface antigen | |
ZA954678B (en) | Monoclonal antibody against cd44v6 | |
GB9615027D0 (en) | Monoclonal antibodies | |
GB8816272D0 (en) | Antibody & antigen | |
GB9510603D0 (en) | Antibody construct |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |